Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIM phase III trial of intravesical mistletoe extract versus mitomycin C in superficial bladder cancer
2013-003446-16Phase 3Active
- Sponsor
- ABNOBA GmbH
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of viscum album and mitomycin c in bladder cancer (2 arms), sponsored by ABNOBA GmbH. Primary endpoint: Time to tumor recurrence. Started Apr 2014; status: active.
02
Drugs
viscum albummitomycin c
03
Conditions
bladder cancer
Beyond the preview
Go deeper on 2013-003446-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003446-16.